on SENSORION (EPA:ALSEN)
Sensorion announces its participation in congresses in March 2025
On February 18, 2025, Sensorion, a biotechnology company specializing in therapies for hearing disorders, announced its participation in several conferences in March 2025. Christine Le Bec, Head of Analytical Development, will speak at the “Innovative Biologics and CMC Challenges vol.2” conference in Charleroi, Belgium on March 12. Her presentation will focus on manufacturing challenges related to AAV vectors.
Sensorion will also be present at BIO-Europe Spring in Milan, Italy, from March 17 to 19, 2025. The objective of these participations is to share their advances in hearing therapies, thus strengthening their position in this crucial medical field. These events will provide the company with a platform to discuss current challenges and innovations in hearing biotechnology.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SENSORION news